Page last updated: 2024-09-02

ecteinascidin 743 and Dermatitis Medicamentosa

ecteinascidin 743 has been researched along with Dermatitis Medicamentosa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beato-Merino, MJ; Gómez-Fernández, C; González-Ramos, J; Herranz-Pinto, P; Mayor-Ibarguren, A; Rodríguez-Bandera, AI	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Dermatitis Medicamentosa

Article	Year
Diffuse Reactive Angioendotheliomatosis Secondary to the Administration of Trabectedin and Pegfilgrastim. The American Journal of dermatopathology, 2015, Volume: 37, Issue:7 Topics: Angiomatosis; Antigens, CD34; Antineoplastic Agents, Alkylating; Cell Proliferation; Dioxoles; Drug Eruptions; Endothelial Cells; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; Recombinant Proteins; Skin Diseases, Vascular; Tetrahydroisoquinolines; Trabectedin	2015

Article

Year

Diffuse Reactive Angioendotheliomatosis Secondary to the Administration of Trabectedin and Pegfilgrastim.

The American Journal of dermatopathology, 2015, Volume: 37, Issue:7

Topics: Angiomatosis; Antigens, CD34; Antineoplastic Agents, Alkylating; Cell Proliferation; Dioxoles; Drug Eruptions; Endothelial Cells; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; Recombinant Proteins; Skin Diseases, Vascular; Tetrahydroisoquinolines; Trabectedin

2015